Wound Management Devices Market

PORTLAND, OR, UNITED STATES, March 2, 2023 /EINPresswire.com/ -- The wound management devices market refers to the segment of the healthcare industry that produces and distributes medical devices used to treat and manage various types of wounds, including chronic wounds, acute wounds, and surgical wounds. These devices are designed to help promote healing, reduce the risk of infection, and manage pain and discomfort associated with wound care.

The wound management devices market includes a range of products, including advanced wound dressings, negative pressure wound therapy devices, compression therapy devices, electromechanical stimulation devices, and others. These products are used in hospitals, clinics, and home care settings to manage wounds caused by a variety of conditions, including diabetes, pressure ulcers, burns, surgical incisions, and traumatic injuries.

The market for wound management devices is driven by several factors, including the growing prevalence of chronic diseases such as diabetes, an aging population, increasing healthcare expenditure, and advances in medical technology. The market is expected to continue to grow in the coming years as the demand for advanced wound care products and technologies increases.

The global wound management devices industry was estimated at $13.39 billion in 2018, and is expected to hit $18.81 billion by 2026, registering a CAGR of 4.3% from 2019 to 2026.

Drivers, restraints, and opportunities-

Rise in geriatric population, increase in diabetic population, and surge in the number of surgeries drive the growth of the global wound management devices market. On the other hand, higher costs of wound care and management and reluctance in adoption of wound care devices hamper the growth of the market. Nevertheless, preference for advanced wound care devices is expected to create lucrative opportunities in the near future.

Request Sample Report at: https://www.alliedmarketresearch.com/request-sample/6637

COVID-19 scenario-

Due to the global pandemic all over the world, the medical devices manufacturers are majorly focusing on essential medical devices production including ventilators and diagnostics.
However, due to the precautionary measures taken by governments in various regions, the supply chain has been hampered. Which may result in shortage of devices in certain locations.
Food and Drugs Administration (FDA), on the other hand, shared a COVID-19 guidance with medical device manufacturers to notify the agency about changes that could affect availability of their products.

Procure Complete Report (220 Pages PDF with Insights, Charts, Tables, and Figures) @ https://www.alliedmarketresearch.com/checkout-final/d0960c62f0220dd16fe67a2e6f9832c9

The therapy devices segment to maintain the lion's share by 2026-

Based on product, the therapy devices segment contributed to more than three fifths of the global wound management devices market revenue in 2018, and is expected to retain its dominance by the end of 2026. Large number of product approvals for therapy devices, reduced length of hospital stays, and improved healing of transplanted skin boost the growth of the segment. Whereas, the wound closure devices segment, would register the fastest CAGR of 4.7% throughout the forecast period. Factors such as rise in use of skin adhesives, tissue sealants, and absorbable sutures in plastic surgeries propel the growth of the segment.

The burns segment to dominate during the estimated period-

Based on application, the burns segment accounted for more than one third of the global wound management devices market share in 2018, and would rule the roost during the study period. Burn injuries are most common, which drives the growth of the segment. On the other hand, the diabetic foot ulcers segment is anticipated to manifest the fastest CAGR of 5.8% from 2019 to 2026. This is attributed to increase in diabetic population across the globe.

For Purchase Enquiry at: https://www.alliedmarketresearch.com/purchase-enquiry/6637

North America to dominate in terms of revenue-

Based on region, North America held the largest share in 2018, garnering more than two-fifths of the global wound management devices market. This is attributed to growing geriatric population along with chronic diseases and rise in awareness regarding wound management devices through medical tourism programs in the region. On the other hand, the Asia-Pacific region is projected to manifest the fastest CAGR of 4.7% by 2026. Rising prevalence of complications related to chronic and lifestyle diseases such as pressure ulcers, venous leg ulcers, and diabetic foot ulcers amongst the population drives the market growth in this region.

Frontrunners in the industry-

Coloplast A/S
Hollister Inc
Baxter International Inc.
ConvaTec Inc.
Derma Sciences Inc.
Johnson & Johnson
3M Company
Medtronic Plc
Mölnlycke Health Care
Smith & Nephew.

"Trending Reports in Healthcare Industry:

Diabetic Nephropathy Market: https://www.alliedmarketresearch.com/diabetic-nephropathy-market-A16604

Monoclonal Antibodies Market: https://www.alliedmarketresearch.com/monoclonal-antibodies-market-A11789

About Us

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Allied Market Research CEO Pawan Kumar is instrumental in inspiring and encouraging everyone associated with the company to maintain high quality of data and help clients in every way possible to achieve success. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

David Correa
Allied Analytics LLP
+ +1 503-894-6022
email us here
Visit us on social media:
Facebook
Twitter
LinkedIn

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.